Northern Trust’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
489,940
+408,916
+505% +$12.8M ﹤0.01% 1818
2025
Q1
$2.72M Buy
81,024
+15,241
+23% +$511K ﹤0.01% 2756
2024
Q4
$2.58M Buy
65,783
+22,377
+52% +$877K ﹤0.01% 2878
2024
Q3
$1.71M Sell
43,406
-3,446
-7% -$136K ﹤0.01% 3095
2024
Q2
$1.83M Sell
46,852
-1,618
-3% -$63.1K ﹤0.01% 2943
2024
Q1
$2.09M Sell
48,470
-13,501
-22% -$581K ﹤0.01% 2932
2023
Q4
$2.85M Sell
61,971
-7,196
-10% -$331K ﹤0.01% 2804
2023
Q3
$2.36M Buy
69,167
+3,684
+6% +$126K ﹤0.01% 2848
2023
Q2
$2.52M Buy
65,483
+4,480
+7% +$172K ﹤0.01% 2877
2023
Q1
$2.18M Buy
61,003
+786
+1% +$28.1K ﹤0.01% 2902
2022
Q4
$2.37M Buy
60,217
+9,326
+18% +$368K ﹤0.01% 2906
2022
Q3
$1.84M Buy
50,891
+2,895
+6% +$105K ﹤0.01% 3050
2022
Q2
$1.46M Buy
47,996
+3,220
+7% +$98K ﹤0.01% 3219
2022
Q1
$1.37M Sell
44,776
-5,820
-12% -$178K ﹤0.01% 3278
2021
Q4
$1.58M Buy
50,596
+12,746
+34% +$398K ﹤0.01% 3339
2021
Q3
$579K Sell
37,850
-6,871
-15% -$105K ﹤0.01% 3717
2021
Q2
$832K Sell
44,721
-5,841
-12% -$109K ﹤0.01% 3575
2021
Q1
$904K Buy
50,562
+3,940
+8% +$70.4K ﹤0.01% 3624
2020
Q4
$717K Sell
46,622
-15,731
-25% -$242K ﹤0.01% 3627
2020
Q3
$690K Buy
62,353
+718
+1% +$7.95K ﹤0.01% 3528
2020
Q2
$772K Buy
61,635
+3,036
+5% +$38K ﹤0.01% 3435
2020
Q1
$664K Buy
58,599
+14,456
+33% +$164K ﹤0.01% 3371
2019
Q4
$579K Buy
44,143
+6,507
+17% +$85.3K ﹤0.01% 3523
2019
Q3
$339K Hold
37,636
﹤0.01% 3632
2019
Q2
$371K Buy
37,636
+13,434
+56% +$132K ﹤0.01% 3637
2019
Q1
$246K Buy
24,202
+11,956
+98% +$122K ﹤0.01% 3723
2018
Q4
$77K Buy
12,246
+1,948
+19% +$12.2K ﹤0.01% 3973
2018
Q3
$136K Buy
+10,298
New +$136K ﹤0.01% 3961